Ontario man wins OHIP battle for US cancer therapy
Ontario man Alex Shved, who has Stage 4 melanoma, challenged OHIP after it denied funding for TIL therapy in Florida costing about US$600,000.
A court ordered the province to reconsider his request.
OHIP later rejected it again, while Ontario changed regulations governing out-of-country drug funding, limiting when patients can receive public coverage abroad.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on timesofindia.indiatimes.com — the content belongs to Times of India.